Diluted Russell's viper venom time and colloidal silica clotting time for the identification of the phospholipid-dependent inhibitors of coagulation

Thrombosis Research

Volumn 85, Issue 5, 1997, Pages 427-431

  Norbis, Francesca ^a   Barbui, Tiziano ^a   Galli, Monica ^a  

^a OSPEDALI RIUNITI   (Italy)

Author keywords

antiphospholipid antibodies; lupus anticoagulant; phospholipid dependent clotting assays; silica clotting time

Indexed keywords

BLOOD CLOTTING INHIBITOR; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; RUSSELL VIPER VENOM; SNAKE VENOM; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ASSAY; BLOOD CLOTTING; BLOOD CLOTTING TIME; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; ANIMALS; ANTIBODIES, ANTIPHOSPHOLIPID; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; BLOOD COAGULATION; COLLOIDS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEPHELOMETRY AND TURBIDIMETRY; PARTIAL THROMBOPLASTIN TIME; RUSSELL'S VIPER; SILICON DIOXIDE; VIPER VENOMS;

EID: 0031104815     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(97)00030-3     Document Type: Article

References (16)

1. HARRIS E.N. Syndrome of the black swan. British J Rheum. 26:1987;324-326.
2. ASHERSON R.A., KHAMASHTA M.A., ORDI-ROS J., et al. The "primary" antiphospholipid syndrome: major clinical and serological features. Medicine. 68:1989;366-374.
3. FINAZZI G., BRANCACCIO V., MOIA M., et al. Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry. Am J Med. 100:1996;530-536.
4. 2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA. 87:1990;4120-4124.
5. GALLI M., COMFURIUS P., MAASSEN C., HEMKER H.C., DEBAETS M.H., VAN BREDA VRIESMAN P.J.C., BARBUI T., ZWAAL R.F.A., BEVERS E.M. Anticardiolipin antibodies (ACA) are directed not to cardiolipin but to a plasma protein cofactor. Lancet. 335:1990;1544-1547.
6. 2-glycoprotein I for binding of anticardiolipin antibodies to cardiolipin. Lancet, 336, 1952-953, 1990.
7. BEVERS E.M., GALLI M., BARBUI T., COMFURIUS P., ZWAAL R.F.A. Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb Haemost. 66:1991;629-632.
8. 2-glycoprotein is potentiated by a distinct subgroup of anticardiolipin antibodies. Thromb Haemost. 68:1993;297-300.
9. 2-glycoprotein I-dependent antiphospholipid antibodies. Blood. 86:1995;617-623.
10. CHANTARANGKUL V., CRIPPA A., TRIPODI A., MANNUCCI P.M. Colloidal Silica Clotting Time (CSCT) in the detection of Lupus Anticoagulant. Thromb Res Suppl. XIII, 79,1991.
11. BRANDT J.T., TRIPLETT D.A., ALVING B., SCHARRER I. Criteria for the diagnosis of lupus anticoagulant: an update. Thromb Haemost. 74:1995;1185-1190.
12. THIAGARAJAN P., PENGO V., SHAPIRO S.S. The use of the dilute Russell's viper venom time for the diagnosis of lupus anticoagulant. Blood. 68:1986;869-874.
13. EXNER T., RICKARD K.A., KRONENBERG H.A. A sensitive test demonstrating lupus anticoagulant and its behavioural patterns. British J Haem. 40:1978;143-151.
14. CHANTARANGKUL V., TRIPODI A., ARBINI A., MANNUCCI P.M. Silica Clotting Time (SCT) as a screening and confirmatory test for detection of the lupus anticoagulants. Thromb Res. 67:1992;355-365.
15. LOIZOU S., McCREA J.D., RUDGE A.C., REYNOLDS R., BOYLE C.C., HARRIS E.N. Measurement of anticardiolipin antibodies by an enzyme-linked immunosorbent assay: standardization and quantitation of results. Clin Exp Immunol. 62:1986;738-744.
16. HARRIS, E.N., GHARAVI, A.E., and HUGHES, G.R.V. The anticardiolipin assay. In: Harris, E.N., Exner, T., Hughes, G.R.V., Asherson, R.A. (eds): Phospholipid-binding antibodies, P.175, Boca Raton, FL, CRC Press, 1991.